大型新盤帶動周末一手成交近300宗
過去周末(6月22-23日)多個大型新盤推售,綜合市場消息,兩日一手成交近300宗,按周升約4倍,當中,新地(00016.HK)屯門御半山II期沽出120伙,新世界(00017.HK)元朗瑧(臣頁)售出120伙;兩盤分別加推68伙及113伙,本周三發售。
此外,恆地(00012.HK)元朗尚悅-嶺、萬科(香港)屯門上源亦錄成交。而永泰(00369.HK)屯門OMA OMA截至昨日下午5時,累收逾400票,超額約1.7倍。
二手方面,中原地產十大屋苑周末僅錄得9宗成交,按周增加28.6%;美聯物業十大藍籌屋苑周末錄得約7宗買賣成交,按周跌約12.5%;利嘉閣地產十大指標屋苑周末錄7宗二手買賣個案,按周持平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.